Fig. 2. In vitro LAK cell–mediated cytotoxicity levels of MNCs. / In vitro LAK cell–mediated cytotoxicity levels of MNCs from G-CSF–mobilized (n = 75) or nonmobilized steady-state (n = 28) donor blood stem cell harvests against K562 (panel A) and Raji (panel B) tumor target cells by means of 51Cr release assay following in vitro activation with IL-2 for 72 hours. Values represent mean percentages of specific cytotoxicity ± SEM from different samples. (For E/T ratios of 12.5:1, P = .005; 25:1,P = .007; 50:1, P = .01; 100:1,P = .05.) ● indicates nonmobilized donors; ▵, G-CSF mobilized donors; *indicates the statistical significance of the value as compared to nonmobilized blood.
Fig. 2.

In vitro LAK cell–mediated cytotoxicity levels of MNCs.

In vitro LAK cell–mediated cytotoxicity levels of MNCs from G-CSF–mobilized (n = 75) or nonmobilized steady-state (n = 28) donor blood stem cell harvests against K562 (panel A) and Raji (panel B) tumor target cells by means of 51Cr release assay following in vitro activation with IL-2 for 72 hours. Values represent mean percentages of specific cytotoxicity ± SEM from different samples. (For E/T ratios of 12.5:1, P = .005; 25:1,P = .007; 50:1, P = .01; 100:1,P = .05.) ● indicates nonmobilized donors; ▵, G-CSF mobilized donors; *indicates the statistical significance of the value as compared to nonmobilized blood.

or Create an Account

Close Modal
Close Modal